Perspective on Providing Partner Notification Services for HIV in Sub-Saharan Africa

2014 ◽  
pp. 17 ◽  
Author(s):  
Potterat
Keyword(s):  
Partner Notification ◽  
Sub Saharan Africa ◽  
Sub Saharan

scholarly journals Acceptability and efficacy of partner notification for curable sexually transmitted infections in sub-Saharan Africa: A systematic review

2018 ◽  
Vol 30 (3) ◽  
pp. 292-303 ◽  
Author(s):  
Sophia Taleghani ◽  
Dvora Joseph-Davey ◽  
Scott B West ◽  
Henry J Klausner ◽  
Adriane Wynn ◽  
...  
Keyword(s):  
Sexually Transmitted Infections ◽  
English Language ◽  
Partner Notification ◽  
Sub Saharan Africa ◽  
Future Research ◽  
Patient Referral ◽  
Sexually Transmitted ◽  
Clinical Trial Registries ◽  
Sub Saharan ◽  
Index Cases

Comprehensive case management of sexually transmitted infections (STIs) includes partner notification. We reviewed the recent literature evaluating the acceptability and efficacy of partner notification strategies (i.e. direct patient referral, provider referral, or expedited partner treatment) for curable STIs in sub-Saharan Africa. We conducted a systematic search following PRISMA guidelines: published January 2008 to June 2017 in the English language, study in sub-Saharan Africa, and discussion of any curable STI with an outcome on partner notification. We searched six electronic databases, conference abstracts, online clinical trial registries, and article bibliographies. The results showed that out of the 74 identified articles, 55 did not meet inclusion criteria. Of the 11 studies evaluating direct patient referral, the proportion of index cases ( n = 4163) who successfully notified sex partner(s) was 53% (range 23-95%). Among those who notified ( n = 1727), 25% (range 0–77%) had partner(s) that sought evaluation (95% CI 0.51–0.54; 95% CI 0.23–0.27). Both provider referral and expedited partner treatment had higher proportions of partner(s) who sought treatment ( n = 208, 69% and n = 44, 84%, respectively). Direct patient referral is the most commonly used and evaluated partner notification strategy for STIs in sub-Saharan Africa with mixed success. We recommend future research to investigate other strategies such as expedited partner treatment.

scholarly journals HIV Partner Notification Is Effective and Feasible in Sub-Saharan Africa: Opportunities for HIV Treatment and Prevention

2011 ◽  
Vol 56 (5) ◽  
pp. 437-442 ◽  
Author(s):  
Lillian B Brown ◽  
William C Miller ◽  
Gift Kamanga ◽  
Naomi Nyirenda ◽  
Pearson Mmodzi ◽  
...  
Keyword(s):  
Partner Notification ◽  
Hiv Treatment ◽  
Sub Saharan Africa ◽  
Treatment And Prevention ◽  
Sub Saharan

scholarly journals Outcomes of and factors associated with partner notification and HIV testing in Northeastern Tanzania.

2020 ◽  
Author(s):  
Furaha Seraphin Lyamuya ◽  
Eva Prosper Muro ◽  
Rachel Manongi ◽  
Declare Mushi ◽  
Irene Kiwelu ◽  
...  
Keyword(s):  
Hiv Testing ◽  
Male Partner ◽  
Partner Notification ◽  
Cross Sectional Study ◽  
Sexual Partners ◽  
Sub Saharan Africa ◽  
Cross Sectional ◽  
Undiagnosed Hiv ◽  
Sub Saharan ◽  
Hiv Status Disclosure

Abstract Background: There is growing evidence of high effectiveness of partner notification (PN) in reaching previously undiagnosed sexual partners. As a result, there is increasing implementation of PN in sub-Saharan Africa. Tanzania, like other countries in the region, has recently expanded PN in HIV testing services. However, this approach is unlikely to yield the expected results if not well implemented. This study aimed to identify gaps and provide recommendations to improve routine implementation of PN in Tanzania.Methods: A cross-sectional study was conducted across seven care and treatment centers (CTCs) in the Kilimanjaro region from November 2018 to April 2019. A total of 297 newly diagnosed HIV infected clients with sexual partner(s) in the past 24 months were recruited at 2 months of their CTC enrollment. Interviews using structured questionnaires were conducted. Descriptive statistics, bivariate and multivariate regression analyses were done.Results: Two-thirds (195) were females. The majority 165 (85%) of those counseled and had partner(s) not previously tested for HIV consented to PN. They all chose passive PN with 102 (62%) reporting successful HIV status disclosure to their partner(s). Reporting disclosure was associated with; being married adjusted odds ratio (aOR 5.1, 95%CI: 2.4–10.9, p < 0.001), in a relationship for > 10 years (aOR 4.9, 95%CI: 1.3–17.6, p = 0.02) and living with the partner(s) (aOR 3.4, 95%CI: 1.3–9.1, p = 0.02). Fifty-three clients (27%) of those with partners not previously tested for HIV reported partner HIV testing following PN, associated with being married (aOR 3.4, 95%CI: 1.3-9, p < 0.02) and living with the partner (aOR 4.5, 95%CI: 1.3–15, p < 0.02). Male partner(s) had lower odds of successful HIV testing (aOR 0.4, 95%CI: 0.2–0.9, p = 0.02). Thirty-seven (67%) of those tested were HIV infected.Conclusions: Detection rate of previously undiagnosed HIV infection among clients referred for HIV-testing through PN was high. However, a significant number of partners did not report for HIV testing after 2 months of index clients CTC enrollment. Initiatives to improve PN are needed with special attention towards those who are single, not living with their partners, in a relationship for < 10 years as well as male sexual partners.

RTS,S/AS01, a vaccine targeting pre-erythrocytic stages of Plasmodium falciparum

2017 ◽  
Vol 1 (6) ◽  
pp. 533-537
Author(s):  
Lorenz von Seidlein ◽  
Borimas Hanboonkunupakarn ◽  
Podjanee Jittmala ◽  
Sasithon Pukrittayakamee
Keyword(s):  
Protective Efficacy ◽  
Age Groups ◽  
Sub Saharan Africa ◽  
Phase Iii ◽  
European Medicines Agency ◽  
Older Children ◽  
Pivotal Phase ◽  
Malaria Epidemiology ◽  
Maximum Benefit ◽  
Sub Saharan

RTS,S/AS01 is the most advanced vaccine to prevent malaria. It is safe and moderately effective. A large pivotal phase III trial in over 15 000 young children in sub-Saharan Africa completed in 2014 showed that the vaccine could protect around one-third of children (aged 5–17 months) and one-fourth of infants (aged 6–12 weeks) from uncomplicated falciparum malaria. The European Medicines Agency approved licensing and programmatic roll-out of the RTSS vaccine in malaria endemic countries in sub-Saharan Africa. WHO is planning further studies in a large Malaria Vaccine Implementation Programme, in more than 400 000 young African children. With the changing malaria epidemiology in Africa resulting in older children at risk, alternative modes of employment are under evaluation, for example the use of RTS,S/AS01 in older children as part of seasonal malaria prophylaxis. Another strategy is combining mass drug administrations with mass vaccine campaigns for all age groups in regional malaria elimination campaigns. A phase II trial is ongoing to evaluate the safety and immunogenicity of the RTSS in combination with antimalarial drugs in Thailand. Such novel approaches aim to extract the maximum benefit from the well-documented, short-lasting protective efficacy of RTS,S/AS01.

Mortality and Society in Sub-Saharan Africa

1993 ◽  
Vol 47 (3) ◽  
pp. 555-556
Author(s):  
Lado Ruzicka
Keyword(s):  
Sub Saharan Africa ◽  
Sub Saharan

Adolescent Suicidality as Seen in Rural Northeastern Uganda

Crisis ◽  
2011 ◽  
Vol 32 (1) ◽  
pp. 43-51 ◽  
Author(s):  
Eugene Kinyanda ◽  
Ruth Kizza ◽  
Jonathan Levin ◽  
Sheila Ndyanabangi ◽  
Catherine Abbo
Keyword(s):  
Low Socioeconomic Status ◽  
Sub Saharan Africa ◽  
Psychosocial Risk ◽  
Psychiatric Nurses ◽  
Health Concern ◽  
Cross Sectional ◽  
Childhood Experiences ◽  
Low Socioeconomic ◽  
Dsm Iv ◽  
Sub Saharan

Background: Suicidal behavior in adolescence is a public health concern and has serious consequences for adolescents and their families. There is, however, a paucity of data on this subject from sub-Saharan Africa, hence the need for this study. Aims: A cross-sectional multistage survey to investigate adolescent suicidality among other things was undertaken in rural northeastern Uganda. Methods: A structured protocol administered by trained psychiatric nurses collected information on sociodemographics, mental disorders (DSM-IV criteria), and psychological and psychosocial risk factors for children aged 3–19 years (N = 1492). For the purposes of this paper, an analysis of a subsample of adolescents (aged 10–19 years; n = 897) was undertaken. Results: Lifetime suicidality in this study was 6.1% (95% CI, 4.6%–7.9%). Conclusions: Factors significantly associated with suicidality included mental disorder, the ecological factor district of residence, factors suggestive of low socioeconomic status, and disadvantaged childhood experiences.

Sign in / Sign up

Export Citation Format

Share Document